Skip Navigation

  1. About Us
    1. Overview
    2. History
    3. Recognition
    4. Offices
  2. Our Practice
    1. Practice Areas
      1. Patents, Utility Models, and Industrial Designs
      2. Trademarks
      3. Copyrights
      4. Corporate, Commercial and Business Law
      5. IP Litigation, Alternative Dispute Resolution
      6. Regulatory Law
      7. Licensing, Tech Transfer & Franchising
      8. Anti-Piracy, Anti-Counterfeiting & Enforcement
    2. Industry Groups
      1. Media, Sports & Entertainment Law Group
      2. Life Science & Pharmaceutical Law Group
  3. Our People
    1. Partners
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. Cesar Ramos, Jr.
      5. Antonio Belaunzaran
      6. Gustavo A. Alcocer
      7. Jose Ignacio De Santiago
      8. Alejandro Luna
      9. Alonso Camargo
      10. Daniel Sanchez
    2. Associates (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Varinia Calleros
      6. Abraham Diaz
      7. Georgina Flores
      8. Pedro Herrera
      9. Carlos Maya
    3. Associates (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
      7. Carlos Woodworth
    4. All Attorneys / Engineers
    5. Firm Administration
  4. Knowledge & Resources
    1. Articles
      1. Trademark Law Articles
        1. Use requirements
        2. Approach to composite marks changed, again
        3. Life Sciences Handbook 2011 - Country Q&A
        4. Mexico should accept secondary meaning
        5. Getting the Deal Through - Trademarks 2011
        6. Pharmaceutical Trademarks 2010/2011 - A Global Guide
        7. No legal basis for banning names derived from INNs
        8. How Latin America tackles cutting-edge IP issues
        9. Specialised IP court corrects IMPI
        10. Protecting trade dress
        11. 43 more items...
      2. Patent Law Articles
        1. Mexico issues regulations to approve biologic drugs
        2. Latin America Roundtable
        3. New regulations pending
        4. The International Comparative Guide
        5. Marketing authorization for pharmaceutical
        6. Approval of follow-on biologics in Mexico
        7. Mexican Linkage Gazette April 2011
        8. Patent Prosecution Highway in Mexico
        9. Life Sciences Handbook 2011 - Country Q&A
        10. Data Package Exclusivity (DPE)
        11. 35 more items...
      3. Copyright Law Articles
        1. Advertising in social media networks
        2. Technology challenges digital rights
        3. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        4. Derechos sobre producción audiovisual
        5. How Latin America tackles cutting-edge IP issues
        6. Copyright Litigation 2010
        7. Legislation and enforcement - Copyrights 2010
        8. Valuing folklore
        9. Protecting novel ideas
        10. Mexico's fair use balancing act
        11. 100 more items...
      4. Corporate Law Articles
        1. Mexico issues Personal Data Protection Rules
        2. How data affects innovation
        3. A practical cross-border
        4. New registry for security interests
        5. The International Comparative Legal Guide to: Merger Control 2011
        6. The International Comparative Legal Guide to: Merger Control 2010
        7. Due diligence issues to consider in M&A
        8. Income expectations in licensing
        9. The reasons for valuation
        10. Amendments proposed to franchise regulation
      5. IP Litigation, ADR Articles
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Regulatory Law Articles
        1. Amendments to the Federal Law for Consumer Protection
        2. Mexico issues Personal Data Protection Rules
        3. New Regulations Pending
        4. Marketing authorization for pharmaceutical products to foreign applicants
        5. Data Package Exclusivity (DPE)
        6. Supreme Court upholds the worth of formulation patents
        7. Pharmaceutical trademarks
        8. Framework for biotherapeutic products established
        9. Pharmaceutical Advertising 2009
        10. New Regulations for pharma industry
        11. 3 more items...
      7. Licensing, Tech Transfer Articles
        1. Creating a secure franchise system
      8. Anti-Piracy, Anti-Counterfeiting Articles
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 3 more items...
      9. Media, Sports & Entertainment Focused Articles
        1. Whither Rental Rights?
        2. Improved protection for personalities
      10. Life Sciences Focused Articles
        1. Latin America Roundtable
        2. New regulations pending
        3. The International Comparative
        4. Approval of follow-on biologics in Mexico
        5. Global Pharmaceutical Linkage Regulations:
        6. Life Sciences Handbook 2011 - Country Q&A
        7. Supreme Court upholds the worth of formulation patents
        8. Repercussions expected on medicine advertising campaign in Mexico
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Trademarks 2009
        11. 1 more item...
    2. Webinar Archive
      1. Webinar - Changes to Mexican Patent and Healthcare Laws for Life Sciences
      2. Webinar - Digital Rights Issues in Copyright Law
      3. Webinar - Data Package Exclusivity Rights in Latin America
    3. Recognition
    4. News
      1. Presumed Guilty - How can a law firm help win an Emmy?
      2. New rules came in force to speed timeframes in administrative appeal proceedings
      3. Recent reforms to the Mexican Industrial Property Law dealing with trademark priority rights
      4. Olivares & Cia. ranking
      5. Data Package Exclusivity (DPE)
      6. Mr. Sergio Olivares Sr's Passing
      7. Pharma Linkage Regulations Supreme Court Decision
      8. Managing IP magazine has recognized Olivares & Cia. as the leading firm for patent work in Mexico
      9. Mexican Congress amends the Patent Law
      10. Implementation of the Federal Law for the Protection of Personal Data in Possession of Private Entities
  5. Events
  6. Offices
  7. Contact Us
  8. Quick guide to Mexico’s regulatory system
    1. Patent regulatory overview
    2. Trademark regulatory overview
    3. Copyright regulatory overview
    4. Corporate & Commercial Regulatory overview

Home » Knowledge & Resources » Articles » Trademark Law Articles » Limitations on advertising regulations

Limitations on advertising regulations

By Juan Carlos Villaseñor, Managing Intellectual Property, International Briefings, November 2009.

The legal regulations of advertising in Mexico are not as developed as in other countries, which in practice provide infringers with more elements to construe their defenses against eventual challenges from competitors and/or consumers.

In addition, and since infringement actions with IMPI for unfair competition are only available when comparison between products or services take place, the legal venue to challenge the contents of advertisements is through the Mexican Association for Self-Regulation and Ethic in Advertising (CONAR) and/or with the General Attorney's Office for Consumers (PROFECO).
CONAR is not a Court of Law but a private entity created by advertisers, advertising agencies and media companies to provide guidelines and rules for the responsible use of advertising media as well as to operate as a mediator between such parties. Members voluntarily agree to comply with the guidelines and rules. Accordingly, the resolutions of CONAR are not binding; however, its recommendations could have some impact among its members at a commercial level. Non-members of CONAR could simply disregard its resolutions and keep using the advertisements of interest with no legal consequences.
PROFECO is a public organism entrusted to promote and protect the interests of consumers. PROFECO can impose fines to infringers and order the removal of the advertisement of interest. PROFECO was created to protect consumers. Accordingly, the eventual challenge in case of advertisements would have to be filed by consumers, not competitors.
Due to the undeveloped nature of the regulations, normally these cases are subject to interpretation and the Authority has to be very cautious in determining a violation. Thus, the advertising regulation in Mexico needs to be modified to broadly protect competitors and/or consumers and to avoid radical changes of criteria from case to case due to subjective interpretations or to the interests involved.